Product Code: ETC13191700 | Publication Date: Apr 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 150 | No. of Figures: 55 | No. of Tables: 32 |
Middle East Parkinsons Disease Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Middle East Parkinsons Disease Market Overview |
3.1 Middle East Regional Macro Economic Indicators |
3.2 Middle East Parkinsons Disease Market Revenues & Volume, 2021 & 2031F |
3.3 Middle East Parkinsons Disease Market - Industry Life Cycle |
3.4 Middle East Parkinsons Disease Market - Porter's Five Forces |
3.5 Middle East Parkinsons Disease Market Revenues & Volume Share, By Countries, 2021 & 2031F |
3.6 Middle East Parkinsons Disease Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.7 Middle East Parkinsons Disease Market Revenues & Volume Share, By Medical Devices, 2021 & 2031F |
3.8 Middle East Parkinsons Disease Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.9 Middle East Parkinsons Disease Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
3.10 Middle East Parkinsons Disease Market Revenues & Volume Share, By Patient Care Setting, 2021 & 2031F |
4 Middle East Parkinsons Disease Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Middle East Parkinsons Disease Market Trends |
6 Middle East Parkinsons Disease Market, 2021 - 2031 |
6.1 Middle East Parkinsons Disease Market, Revenues & Volume, By Drug Class, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Middle East Parkinsons Disease Market, Revenues & Volume, By Levodopa/Carbidopa, 2021 - 2031 |
6.1.3 Middle East Parkinsons Disease Market, Revenues & Volume, By Dopamine Receptor Agonists, 2021 - 2031 |
6.1.4 Middle East Parkinsons Disease Market, Revenues & Volume, By MAO-Inhibitors, 2021 - 2031 |
6.1.5 Middle East Parkinsons Disease Market, Revenues & Volume, By COMT-Inhibitors, 2021 - 2031 |
6.1.6 Middle East Parkinsons Disease Market, Revenues & Volume, By Anticholinergics, 2021 - 2031 |
6.1.7 Middle East Parkinsons Disease Market, Revenues & Volume, By Other Drugs, 2021 - 2031 |
6.2 Middle East Parkinsons Disease Market, Revenues & Volume, By Medical Devices, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Middle East Parkinsons Disease Market, Revenues & Volume, By Deep Brain Stimulation (DBS) Devices, 2021 - 2031 |
6.2.3 Middle East Parkinsons Disease Market, Revenues & Volume, By Carbidopa/Levodopa Enteral Suspension (Duopa) Delivery Devices, 2021 - 2031 |
6.3 Middle East Parkinsons Disease Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 Middle East Parkinsons Disease Market, Revenues & Volume, By Oral, 2021 - 2031 |
6.3.3 Middle East Parkinsons Disease Market, Revenues & Volume, By Transdermal, 2021 - 2031 |
6.3.4 Middle East Parkinsons Disease Market, Revenues & Volume, By Subcutaneous, 2021 - 2031 |
6.3.5 Middle East Parkinsons Disease Market, Revenues & Volume, By Intestinal Infusion, 2021 - 2031 |
6.3.6 Middle East Parkinsons Disease Market, Revenues & Volume, By Others, 2021 - 2031 |
6.4 Middle East Parkinsons Disease Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
6.4.1 Overview & Analysis |
6.4.2 Middle East Parkinsons Disease Market, Revenues & Volume, By Hospital Pharmacies, 2021 - 2031 |
6.4.3 Middle East Parkinsons Disease Market, Revenues & Volume, By Clinics, 2021 - 2031 |
6.4.4 Middle East Parkinsons Disease Market, Revenues & Volume, By Retail Pharmacies, 2021 - 2031 |
6.4.5 Middle East Parkinsons Disease Market, Revenues & Volume, By Online Pharmacies, 2021 - 2031 |
6.5 Middle East Parkinsons Disease Market, Revenues & Volume, By Patient Care Setting, 2021 - 2031 |
6.5.1 Overview & Analysis |
6.5.2 Middle East Parkinsons Disease Market, Revenues & Volume, By Hospitals, 2021 - 2031 |
6.5.3 Middle East Parkinsons Disease Market, Revenues & Volume, By Clinics, 2021 - 2031 |
7 Middle East Parkinsons Disease Market, By Countries, 2021 - 2031 |
7.1 Overview & Analysis |
7.2 Middle East Parkinsons Disease Market, Revenues & Volume, By Drug Class, 2021 - 2031 |
7.2.1 Saudi Arabia Parkinsons Disease Market, Revenues & Volume, By Drug Class, 2021 - 2031 |
7.2.2 UAE Parkinsons Disease Market, Revenues & Volume, By Drug Class, 2021 - 2031 |
7.2.3 Kuwait Parkinsons Disease Market, Revenues & Volume, By Drug Class, 2021 - 2031 |
7.2.4 Qatar Parkinsons Disease Market, Revenues & Volume, By Drug Class, 2021 - 2031 |
7.2.5 Bahrain Parkinsons Disease Market, Revenues & Volume, By Drug Class, 2021 - 2031 |
7.2.6 Oman Parkinsons Disease Market, Revenues & Volume, By Drug Class, 2021 - 2031 |
7.2.7 Turkey Parkinsons Disease Market, Revenues & Volume, By Drug Class, 2021 - 2031 |
7.2.8 Rest of Middle East Parkinsons Disease Market, Revenues & Volume, By Drug Class, 2021 - 2031 |
7.3 Middle East Parkinsons Disease Market Revenues & Volume Share, By Medical Devices, 2021 & 2031F |
7.3.1 Saudi Arabia Parkinsons Disease Market, Revenues & Volume, By Medical Devices, 2021 - 2031 |
7.3.2 UAE Parkinsons Disease Market, Revenues & Volume, By Medical Devices, 2021 - 2031 |
7.3.3 Kuwait Parkinsons Disease Market, Revenues & Volume, By Medical Devices, 2021 - 2031 |
7.3.4 Qatar Parkinsons Disease Market, Revenues & Volume, By Medical Devices, 2021 - 2031 |
7.3.5 Bahrain Parkinsons Disease Market, Revenues & Volume, By Medical Devices, 2021 - 2031 |
7.3.6 Oman Parkinsons Disease Market, Revenues & Volume, By Medical Devices, 2021 - 2031 |
7.3.7 Turkey Parkinsons Disease Market, Revenues & Volume, By Medical Devices, 2021 - 2031 |
7.3.8 Rest of Middle East Parkinsons Disease Market, Revenues & Volume, By Medical Devices, 2021 - 2031 |
7.4 Middle East Parkinsons Disease Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
7.4.1 Saudi Arabia Parkinsons Disease Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
7.4.2 UAE Parkinsons Disease Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
7.4.3 Kuwait Parkinsons Disease Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
7.4.4 Qatar Parkinsons Disease Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
7.4.5 Bahrain Parkinsons Disease Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
7.4.6 Oman Parkinsons Disease Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
7.4.7 Turkey Parkinsons Disease Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
7.4.8 Rest of Middle East Parkinsons Disease Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
7.5 Middle East Parkinsons Disease Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
7.5.1 Saudi Arabia Parkinsons Disease Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
7.5.2 UAE Parkinsons Disease Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
7.5.3 Kuwait Parkinsons Disease Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
7.5.4 Qatar Parkinsons Disease Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
7.5.5 Bahrain Parkinsons Disease Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
7.5.6 Oman Parkinsons Disease Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
7.5.7 Turkey Parkinsons Disease Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
7.5.8 Rest of Middle East Parkinsons Disease Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
7.6 Middle East Parkinsons Disease Market, Revenues & Volume, By Patient Care Setting, 2021 - 2031 |
7.6.1 Saudi Arabia Parkinsons Disease Market, Revenues & Volume, By Patient Care Setting, 2021 - 2031 |
7.6.2 UAE Parkinsons Disease Market, Revenues & Volume, By Patient Care Setting, 2021 - 2031 |
7.6.3 Kuwait Parkinsons Disease Market, Revenues & Volume, By Patient Care Setting, 2021 - 2031 |
7.6.4 Qatar Parkinsons Disease Market, Revenues & Volume, By Patient Care Setting, 2021 - 2031 |
7.6.5 Bahrain Parkinsons Disease Market, Revenues & Volume, By Patient Care Setting, 2021 - 2031 |
7.6.6 Oman Parkinsons Disease Market, Revenues & Volume, By Patient Care Setting, 2021 - 2031 |
7.6.7 Turkey Parkinsons Disease Market, Revenues & Volume, By Patient Care Setting, 2021 - 2031 |
7.6.8 Rest of Middle East Parkinsons Disease Market, Revenues & Volume, By Patient Care Setting, 2021 - 2031 |
8 Middle East Parkinsons Disease Market Key Performance Indicators |
9 Middle East Parkinsons Disease Market - Export/Import By Countries Assessment |
10 Middle East Parkinsons Disease Market - Opportunity Assessment |
10.1 Middle East Parkinsons Disease Market Opportunity Assessment, By Countries, 2021 & 2031F |
10.2 Middle East Parkinsons Disease Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
10.3 Middle East Parkinsons Disease Market Opportunity Assessment, By Medical Devices, 2021 & 2031F |
10.4 Middle East Parkinsons Disease Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
10.5 Middle East Parkinsons Disease Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10.6 Middle East Parkinsons Disease Market Opportunity Assessment, By Patient Care Setting, 2021 & 2031F |
11 Middle East Parkinsons Disease Market - Competitive Landscape |
11.1 Middle East Parkinsons Disease Market Revenue Share, By Companies, 2022 |
11.2 Middle East Parkinsons Disease Market Competitive Benchmarking, By Operating and Technical Parameters |
12 Top 10 Company Profiles |
13 Recommendations |
14 Disclaimer |